thesis-toulmin
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q34688644-D49BF92E-4CED-4A93-A159-7A324EE3EE51
Q34688644-D49BF92E-4CED-4A93-A159-7A324EE3EE51
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34688644-D49BF92E-4CED-4A93-A159-7A324EE3EE51
CALGB 150905 (Alliance): rituximab broadens the antilymphoma response by activating unlicensed NK cells.
P2860
Q34688644-D49BF92E-4CED-4A93-A159-7A324EE3EE51
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34688644-D49BF92E-4CED-4A93-A159-7A324EE3EE51
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a74ca1b0f334413f1ec50b92bc157fa05f2a3f95
P2860
A phase 1 trial of the anti-KIR antibody IPH2101 in patients with relapsed/refractory multiple myeloma